We need to address this problem.
Let me echo what you said about the hearing and the value of it. I totally agree.
And the problem I have is if we grant exclusivity, we are essentially giving the pharmaceutical free rein to charge whatever it wants during...
As Members of Congress, we typically speak about treating disease in sound bites.
I seriously question whether a lengthy exclusivity will achieve the kind of savings we all hope to see.
Cures and cutting-edge medicines are of no value if their high costs put them out of reach of the patients who need them.
I do think that is important to have but, I mean, it is always going to be individual case too, though, obviously.
For many years, there has been a lot of discussion about how we move our health care system into one of quality and efficiency.
I am amazed by how much variation exists in the care provided in the post-acute setting.
We believe, and we have made a recommendation along these lines, you can take the elements from that instrument...
We all agree that the Federal Government and Congress can play a role to help accelerate the discovery, development and delivery of promisin...